Skip to main content
Clinical Trials/EUCTR2006-001487-23-LV
EUCTR2006-001487-23-LV
Active, not recruiting
Not Applicable

A Double Blind Randomized Controlled Study of the Effiacy and Safety of Topical Sterile 5% Lidocaine Patch in the Treatment of Postoperative Pain Due to Plastic Surgery of the Breast

Teikoku Pharma USA, Inc.0 sites120 target enrollmentJanuary 11, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Pain Due to the Plastic Surgery of the Breast
Sponsor
Teikoku Pharma USA, Inc.
Enrollment
120
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 11, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy females 18\-60 years of age with a planned surgery for plastic surgery of the breast;
  • Agrees to sign and date an Ethics Committee approved informed consent;
  • Must be undergoing plastic surgery of both breasts for reduction or enlargement;
  • In good health on the basis of medical history, physical examination, ECG and routine laboratory tests per the judgement of the clinicial;
  • Is reliable and mentally competent to complete study diaries;
  • Agrees to use the study medication as required by the protocol;
  • I able to read, speak and understand Latvian, Russian or English;
  • Is using an acceptable birth control method;
  • Is available for the study visits and telepfone checks during the duration of treatment (6\-8 days following surgery)
  • Are the trial subjects under 18? no

Exclusion Criteria

  • Females with any malignancy or suspected malignancy, or has received treatment for a malignancy within the past 5 years,
  • Has used analgesics, steroids, or sedatives in the treatment of the chronic disease within the past 3 months,
  • Has a history of hypersensivity to lidocaine, aspirin or other analgesics,
  • has chronic renal or hepatic disease having serum creatinine levels 1\.25 times above the upper limit of normal and AST/ALT levels 1\.5 times above the upper limit of normal,
  • Smokes more than 15 cigarettes per day,
  • Is a known alchocol or drug abuser,
  • Needs more extensive surgery such as mastectomy or reconstruction of the breast,
  • Is having breast augmentation via transaxial or transumbilical incisions,
  • Has had previous surgery in the same area,
  • Has participated in any other clinivcal trial within the past 60 days,

Outcomes

Primary Outcomes

Not specified

Similar Trials